Fermenta Biotech Ltd vs Venus Remedies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Fermenta Biotech Ltd is ₹ 338.8 as of 12 Jun 15:30 . The P/E Ratio of Fermenta Biotech Ltd changed from 15.9 on March 2021 to 10.4 on March 2025 . This represents a CAGR of -8.14% over 5 yearsThe P/E Ratio of Venus Remedies Ltd changed from 5.5 on March 2021 to 8.8 on March 2025 . This represents a CAGR of 9.86% over 5 years The Market Cap of Fermenta Biotech Ltd changed from ₹ 736.66 crore on March 2021 to ₹ 805.08 crore on March 2025 . This represents a CAGR of 1.79% over 5 yearsThe Market Cap of Venus Remedies Ltd changed from ₹ 338.91 crore on March 2021 to ₹ 400.47 crore on March 2025 . This represents a CAGR of 3.39% over 5 years The revenue of Fermenta Biotech Ltd for the Mar '26 is ₹ 135.72 crore as compare to the Dec '25 revenue of ₹ 140.48 crore. This represent the decline of -3.39% The revenue of Venus Remedies Ltd for the Mar '26 is ₹ 264.35 crore as compare to the Dec '25 revenue of ₹ 182.78 crore. This represent the growth of 44.63% The ebitda of Fermenta Biotech Ltd for the Mar '26 is ₹ 34.14 crore as compare to the Dec '25 ebitda of ₹ 25.89 crore. This represent the growth of 31.87% The ebitda of Venus Remedies Ltd for the Mar '26 is ₹ 68.37 crore as compare to the Dec '25 ebitda of ₹ 40.04 crore. This represent the growth of 70.75% The net profit of Fermenta Biotech Ltd changed from ₹ -5.93 crore to ₹ 18.6 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Venus Remedies Ltd changed from ₹ 1.22 crore to ₹ 47.5 crore over 8 quarters. This represents a CAGR of 523.97% The Dividend Payout of Fermenta Biotech Ltd changed from 13.87 % on March 2021 to 10.78 % on March 2025 . This represents a CAGR of -4.92% over 5 yearsThe Dividend Payout of Venus Remedies Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fermenta Biotech Ltd

Fermenta Biotech Limited was formerly incorporated as 'Duphar-Interfran Limited' in May, 1951.
The Company name was changed to 'DIL Limited' in September, 2003 and later on, was changed to 'Fermenta Biotech Limited' on October 17, 2019.
The Company is presently engaged in pharmaceuticals, manufacturing and marketing Active Pharmaceutical Ingredients, biotechnology, environmental solutions and renting of properties. Initially, Company manufactured and sold toothpaste, anti-septic lotion and pharmaceutical specialities.
It entered into collaborations with Philips-Duphar, Amsterdam (Solvay Duphar), and the Crookes Laboratories, London.
These collaborators participated in the equity capital of the Company to the extent of 25% each. In 1964, Company entered into a collaboration with Solvay Duphar to manufacture vitamin D3.

About Venus Remedies Ltd

Incorporated in 1989 Venus Remedies Limited, formerly known as Venus Glucose Pvt Ltd, was converted into Public Limited Company in 1994 and then changed into Venus Remedies Limited.
The Company was promoted and managed by Chaudhary & Family.
The Company is one of the handful player in pharmaceutical sector to launch injectables globally.
It has manufacturing facilities in Panchkula and Baddi , and research and development centre under the name of Venus Medicine Research Centre (in India). At present, Venus focuses on specialized therapeutic areas including anti-infectives (antibiotics), oncology, neurology, pain management, and skin and wound care.
In priority, the Company was mainly engaged in I/V Fluids & Injectables, Ceftazidime, Amlodipine, Gliclazide, Lisinopril, etc. The production was started in 1991 with Intravenous/Intramuscular injectible forms at Panchkula district at Haryana.

FAQs for the comparison of Fermenta Biotech Ltd and Venus Remedies Ltd

Which company has a larger market capitalization, Fermenta Biotech Ltd or Venus Remedies Ltd?

Market cap of Fermenta Biotech Ltd is 997 Cr while Market cap of Venus Remedies Ltd is 2,407 Cr

What are the key factors driving the stock performance of Fermenta Biotech Ltd and Venus Remedies Ltd?

The stock performance of Fermenta Biotech Ltd and Venus Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fermenta Biotech Ltd and Venus Remedies Ltd?

As of June 14, 2026, the Fermenta Biotech Ltd stock price is INR ₹338.8. On the other hand, Venus Remedies Ltd stock price is INR ₹1801.25.

How do dividend payouts of Fermenta Biotech Ltd and Venus Remedies Ltd compare?

To compare the dividend payouts of Fermenta Biotech Ltd and Venus Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.